Crosspoint Capital Strategies’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-591
Closed -$167K 13
2017
Q4
$167K Buy
591
+156
+36% +$3.68K 0.01% 59
2017
Q3
$8K Buy
+435
New +$7.31K 0.01% 90

Other funds holding AXGN

Crosspoint Capital Strategies's AXGN Position: Q1 2018 in Review

Crosspoint Capital Strategies sold out of Axogen (AXGN) in Q1 2018, closing a stake of 591 shares — an estimated $167K sold.

Crosspoint Capital Strategies first reported a position in AXGN in Q3 2017 and held it in 2 quarters. The position peaked at $167K in Q4 2017. 147 funds tracked by Wall St. Rank hold AXGN as of Q1 2018.

  • Crosspoint Capital Strategies reported no remaining Axogen position as of Q1 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 591 Axogen shares in Q1 2018, an estimated $167K.
  • Crosspoint Capital Strategies first reported a position in Axogen in Q3 2017 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Axogen position peaked at $167K in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Axogen as of Q1 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2018, filed 14 May 2018.